| RRC ID |
33956
|
| 著者 |
Kawashima H, Ogose A, Yoshizawa T, Kuwano R, Hotta Y, Hotta T, Hatano H, Kawashima H, Endo N.
|
| タイトル |
Expression of the coxsackievirus and adenovirus receptor in musculoskeletal tumors and mesenchymal tissues: efficacy of adenoviral gene therapy for osteosarcoma.
|
| ジャーナル |
Cancer Sci
|
| Abstract |
Recombinant adenovirus is used as a competent vector in a wide spectrum of cancer gene therapies. Adenovirus infection depends on coxsackievirus and adenovirus receptor (CAR)-mediated virus attachment to the cell surface. However, the expression levels of CAR and the efficiency of adenoviral gene transduction in musculoskeletal tumors have not been systematically investigated. To study the feasibility of gene therapy in musculoskeletal tumors, the expression levels of CAR and the antiproliferative effect of an adenovirally transduced wild-type p53 tumor suppressor gene were examined in 15 distinct musculoskeletal tumor cell lines, 19 tumor tissue samples, and the corresponding pathologically unremarkable mesenchymal tissues. The expression levels of the CAR gene were significantly higher in six of seven osteosarcoma cell lines and two of five osteosarcoma tissue samples than in the other cell lines, musculoskeletal tumors, and mesenchymal tissues. CAR expression levels were closely correlated with adenoviral gene transduction efficiency and the antiproliferative effect of a transduced adenoviral p53 gene in the tested cell lines. In addition, an immunocytochemical study confirmed that transfected green fluorescent protein (GFP) borne by Ad-CAG-GFP was expressed at the cell surface of CAR-positive cells. These results indicate that CAR expression is a critical determinant of transduction efficiency in adenovirus-based gene therapy. Most osteosarcomas appeared to express high levels of CAR, and thus adenovirus-mediated p53 gene therapy is likely to be suitable for the treatment of such tumors.
|
| 巻・号 |
94(1)
|
| ページ |
70-5
|
| 公開日 |
2003-1-1
|
| DOI |
10.1111/j.1349-7006.2003.tb01354.x
|
| PMID |
12708477
|
| MeSH |
Adenoviruses, Human / genetics
Adenoviruses, Human / metabolism*
Alternative Splicing
Bone Neoplasms / metabolism*
Bone Neoplasms / pathology
Bone Neoplasms / therapy
Cell Division / genetics
Chondrosarcoma / metabolism
Chondrosarcoma / pathology
Coxsackie and Adenovirus Receptor-Like Membrane Protein
Fibrosarcoma / metabolism
Fibrosarcoma / pathology
Genes, Reporter
Genes, p53
Genetic Therapy*
Genetic Vectors / genetics
Genetic Vectors / metabolism
Genetic Vectors / therapeutic use*
Green Fluorescent Proteins
HeLa Cells / metabolism
Histiocytoma, Benign Fibrous / metabolism
Histiocytoma, Benign Fibrous / pathology
Humans
Liposarcoma / metabolism
Liposarcoma / pathology
Luminescent Proteins / biosynthesis
Luminescent Proteins / genetics
Mesoderm / metabolism*
Neoplasm Proteins / analysis*
Neoplasm Proteins / genetics
Nerve Sheath Neoplasms / metabolism
Nerve Sheath Neoplasms / pathology
Neuroectodermal Tumors, Primitive / metabolism
Neuroectodermal Tumors, Primitive / pathology
Osteosarcoma / metabolism*
Osteosarcoma / pathology
Osteosarcoma / therapy
RNA, Messenger / genetics
RNA, Messenger / metabolism
RNA, Neoplasm / genetics
RNA, Neoplasm / metabolism
Receptors, Virus / analysis*
Receptors, Virus / genetics
Recombinant Fusion Proteins / biosynthesis
Recombinant Fusion Proteins / genetics
Reverse Transcriptase Polymerase Chain Reaction
Rhabdomyosarcoma, Alveolar / metabolism
Rhabdomyosarcoma, Alveolar / pathology
Sarcoma, Synovial / metabolism
Sarcoma, Synovial / pathology
Transduction, Genetic
Tumor Cells, Cultured / metabolism
Tumor Suppressor Protein p53 / physiology
|
| IF |
4.966
|
| 引用数 |
24
|
|
WOS 分野
|
ONCOLOGY
|
| リソース情報 |
| 遺伝子材料 |
Ax1 CA gfp (RDB01727) |
| ヒト・動物細胞 |
HeLa(RCB0007) |
